Found: 2796
Select item for more details and to access through your institution.
Non-invasive liver fibrosis assessment and HCV treatment initiation within a systematic screening program in HIV/HCV coinfected patients.
- Published in:
- Wiener Klinische Wochenschrift, 2018, v. 130, n. 3/4, p. 105, doi. 10.1007/s00508-017-1231-x
- By:
- Publication type:
- Article
Anti-HCV treatment with ombitasvir/paritaprevir/ritonavir ± dasabuvir is associated with increased bile acid levels and pruritus.
- Published in:
- 2017
- By:
- Publication type:
- Report
Peginterferon alfa related psoriasis in a patient with acute hepatitis C and review of the literature.
- Published in:
- 2013
- By:
- Publication type:
- Report
Economic evaluation of Zepatier for the management of HCV in the Italian scenario.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Cost-effectiveness analysis of the use of daclatasvir + sofosbuvir + ribavirin (16 weeks and 12 weeks) vs sofosbuvir + ribavirin (16 weeks and 24 weeks) for the treatment of cirrhotic patients affected with hepatitis C virus genotype 3 in Italy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Health state utilities associated with attributes of treatments for hepatitis C.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Pricing of forthcoming therapies for hepatitis C in Europe: beyond cost-effectiveness?
- Published in:
- 2015
- By:
- Publication type:
- Editorial
Comparative Molecular Field Analysis and Molecular Docking Studies on Quinolinone Derivatives Indicate Potential Hepatitis C Virus Inhibitors.
- Published in:
- Cell Biochemistry & Biophysics, 2019, v. 77, n. 2, p. 139, doi. 10.1007/s12013-019-00867-4
- By:
- Publication type:
- Article
Gene Polymorphisms of IL-10 and MxA in Responders and Non-responders to Interferon Therapy in HCV Egyptian Patients Genotype 4.
- Published in:
- Cell Biochemistry & Biophysics, 2015, v. 71, n. 2, p. 617, doi. 10.1007/s12013-014-0241-9
- By:
- Publication type:
- Article
Is rs8099917 Polymorphism of IL-28B Gene a Good Predictor of Response to Therapy of HCV than rs12979860? An Egyptian Study.
- Published in:
- Cell Biochemistry & Biophysics, 2015, v. 71, n. 1, p. 307, doi. 10.1007/s12013-014-0199-7
- By:
- Publication type:
- Article
Identification of Treatment Efficacy-Related Host Factors in Chronic Hepatitis C by ProteinChip Serum Analysis.
- Published in:
- Molecular Medicine, 2011, v. 17, n. 1/2, p. 70, doi. 10.2119/molmed.2010.00124
- By:
- Publication type:
- Article
Treatment of acute hepatitis C: recommendations from an expert panel of the Italian Society of Infectious and Tropical Diseases.
- Published in:
- Infection, 2018, v. 46, n. 2, p. 183, doi. 10.1007/s15010-017-1107-z
- By:
- Publication type:
- Article
Current and future challenges in HCV: insights from an Italian experts panel.
- Published in:
- Infection, 2018, v. 46, n. 2, p. 147, doi. 10.1007/s15010-017-1093-1
- By:
- Publication type:
- Article
The impact of a successful treatment of hepatitis C virus on glyco-metabolic control in diabetic patients: a systematic review and meta-analysis.
- Published in:
- Acta Diabetologica, 2019, v. 56, n. 3, p. 341, doi. 10.1007/s00592-018-1257-1
- By:
- Publication type:
- Article
Pathophysiology of CKD 1.
- Published in:
- 2007
- Publication type:
- Abstract
Serum Fibrosis Marker Panels FIB-4 Index and Aspartate Aminotransferase (AST)-to-Platelet Ratio Index (APRI) Are Equivalent to AST Alone at Predicting Liver Fibrosis in a Cohort of 1731 Patients Infected with Hepatitis C Virus.
- Published in:
- Journal of Applied Laboratory Medicine, 2017, p. 76, doi. 10.1373/jalm.2016.022509
- By:
- Publication type:
- Article
How can general practitioners support people who inject drugs to engage with directacting antiviral treatment for hepatitis C? A qualitative study.
- Published in:
- Australian Journal of General Practice, 2021, v. 50, n. 10, p. 716, doi. 10.31128/ajgp-03-21-5899
- By:
- Publication type:
- Article
Treating chronic hepatitis C in general practice.
- Published in:
- Australian Journal of General Practice, 2021, v. 50, n. 10, p. 697, doi. 10.31128/ajgp-06-21-6029
- By:
- Publication type:
- Article
Reply to miR-122, IL28B genotype and the response to interferon in chronic hepatitis C virus infection.
- Published in:
- Nature Reviews Immunology, 2013, v. 13, n. 12, p. 902, doi. 10.1038/nri3463-c2
- By:
- Publication type:
- Article
Talking About Hepatitis C: FAQs From Young Adults Who Inject Drugs.
- Published in:
- Health Promotion Practice, 2018, v. 19, n. 6, p. 815, doi. 10.1177/1524839918799455
- By:
- Publication type:
- Article
Acute Hepatitis Caused by Genotype 4 HCV Presenting with Microangiopathic Hemolytic Anemia.
- Published in:
- ACG Case Reports Journal, 2018, v. 5, p. 1, doi. 10.14309/crj.2018.73
- By:
- Publication type:
- Article
Staff-Facilitated Telemedicine Care Delivery for Treatment of Hepatitis C Infection among People Who Inject Drugs.
- Published in:
- Healthcare (2227-9032), 2024, v. 12, n. 7, p. 715, doi. 10.3390/healthcare12070715
- By:
- Publication type:
- Article
Facing HCV as a Major Public Healthcare Threat in Italy: Epidemiology and Micro-Elimination Pathways among Underserved Populations.
- Published in:
- Healthcare (2227-9032), 2023, v. 11, n. 14, p. 2109, doi. 10.3390/healthcare11142109
- By:
- Publication type:
- Article
PP110 Economic Impact Of Therapeutic Regime Reduction In The Hepatitis C Virus Infection.
- Published in:
- 2017
- By:
- Publication type:
- Abstract
Pegylated and non-pegylated interferon-alfa and ribavirin for the treatment of mild chronic hepatitis C: A systematic review and meta-analysis.
- Published in:
- International Journal of Technology Assessment in Health Care, 2009, v. 25, n. 1, p. 56, doi. 10.1017/S0266462309090084
- By:
- Publication type:
- Article
Expanding Capacity for Hepatitis C Treatment in the United States: Team-Based Care and Use of Nonphysician Providers.
- Published in:
- Journal of the International Association of Providers of AIDS Care, 2015, v. 14, n. 2, p. 112, doi. 10.1177/2325957414560065
- By:
- Publication type:
- Article
Evaluation of Hepatitis C Virus Genotype Results in İzmir Atatürk Training and Research Hospital.
- Published in:
- Viral Hepatitis Journal / Viral Hepatit Dergisi, 2019, v. 25, n. 2, p. 59, doi. 10.4274/vhd.galenos.2019.2019.0011
- By:
- Publication type:
- Article
Sixteen-year Prognosis of Treatment-naive Patients with Hepatitis C Infection.
- Published in:
- Viral Hepatitis Journal / Viral Hepatit Dergisi, 2019, v. 25, n. 1, p. 19, doi. 10.4274/vhd.galenos.2018.0026
- By:
- Publication type:
- Article
Distribution of Hepatitis C Virus Genotypes in Aydın Province.
- Published in:
- Viral Hepatitis Journal / Viral Hepatit Dergisi, 2018, v. 24, n. 3, p. 70, doi. 10.4274/vhd.2018.0019
- By:
- Publication type:
- Article
Epidemiology of Hepatitis C in North Cyprus.
- Published in:
- Viral Hepatitis Journal / Viral Hepatit Dergisi, 2018, v. 24, n. 1, p. 21, doi. 10.4274/vhd.0006
- By:
- Publication type:
- Article
Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial.
- Published in:
- Scientific Reports, 2015, p. 11710, doi. 10.1038/srep11710
- By:
- Publication type:
- Article
Adenovirus vectors lacking virus-associated RNA expression enhance shRNA activity to suppress hepatitis C virus replication.
- Published in:
- Scientific Reports, 2013, p. 1, doi. 10.1038/srep03575
- By:
- Publication type:
- Article
Cynaropicrin: A Comprehensive Research Review and Therapeutic Potential As an Anti-Hepatitis C Virus Agent.
- Published in:
- Frontiers in Pharmacology, 2016, v. 7, p. 1, doi. 10.3389/fphar.2016.00472
- By:
- Publication type:
- Article
Pilot study of pegylated interferon-alpha 2a in dialysis patients with chronic hepatitis C virus infection.
- Published in:
- Nephrology, 2007, v. 12, n. 1, p. 11, doi. 10.1111/j.1440-1797.2006.00662.x
- By:
- Publication type:
- Article
High efficacy of sofosbuvir/velpatasvir and impact of baseline resistance‐associated substitutions in hepatitis C genotype 3 infection.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 9, p. 1288, doi. 10.1111/apt.14592
- By:
- Publication type:
- Article
Direct‐acting antiviral treatment for hepatitis C virus infection and risk of incident liver cancer: a retrospective cohort study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 9, p. 1278, doi. 10.1111/apt.14593
- By:
- Publication type:
- Article
Hepatitis C virus re‐treatment in the era of direct‐acting antivirals: projections in the USA.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 7, p. 1023, doi. 10.1111/apt.14527
- By:
- Publication type:
- Article
Editorial: direct‐acting antivirals significantly improve quality of life in patients with hepatitis C virus infection—Author's reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 4, p. 537, doi. 10.1111/apt.14481
- By:
- Publication type:
- Article
Editorial: direct‐acting antivirals significantly improve quality of life in patients with hepatitis C virus infection.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Hepatitis B reactivation and outcomes in persons treated with directly acting antiviral agents against hepatitis C virus: results from ERCHIVES.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 3, p. 412, doi. 10.1111/apt.14426
- By:
- Publication type:
- Article
Editorial: ribavirin continues to play a role in treatment with direct-acting antivirals for hepatitis C virus-infected patients with decompensated cirrhosis.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
Barriers to hepatitis C treatment in the era of direct-acting anti-viral agents.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 10, p. 992, doi. 10.1111/apt.14328
- By:
- Publication type:
- Article
Editorial: good news to patients with thalassaemia-HCV clearance made easy with direct-acting antivirals.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
No evidence of hepatitis B virus reactivation in patients with resolved infection treated with direct-acting antivirals for hepatitis C in a large real-world cohort.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 4, p. 432, doi. 10.1111/apt.14177
- By:
- Publication type:
- Article
Editorial: hepatitis C direct acting antiviral agents and the kidney-authors' reply.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
Editorial: hepatitis C direct acting anti-viral agents and the kidney.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
Letter: HBV/ HCV coinfection in the era of direct-acting antivirals.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 2, p. 211, doi. 10.1111/apt.14127
- By:
- Publication type:
- Article
Treatment of HCV infection in liver transplant recipients with ledipasvir and sofosbuvir without ribavirin.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 11, p. 1427, doi. 10.1111/apt.14059
- By:
- Publication type:
- Article
Letter: chronic hepatitis C genotype 3 infection - still a hurdle toward a direct-acting anti-viral-induced HCV cure?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 10, p. 1376, doi. 10.1111/apt.14042
- By:
- Publication type:
- Article
Transformation of hepatitis C antiviral treatment in a national healthcare system following the introduction of direct antiviral agents.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 9, p. 1201, doi. 10.1111/apt.14021
- By:
- Publication type:
- Article